Patent: 10,335,463
✉ Email this page to a colleague
Summary for Patent: 10,335,463
| Title: | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| Abstract: | Embodiment of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many embodiments provide a swallowable device for delivering the agents. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade to release the drug into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract. |
| Inventor(s): | Imran; Mir (Los Altos Hills, CA) |
| Assignee: | Rani Therapeutics, LLC (San Jose, CA) |
| Application Number: | 15/824,976 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,335,463
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Eli Lilly And Company | HUMATROPE | somatropin | For Injection | 019640 | June 23, 1987 | ⤷ Start Trial | 2037-11-28 |
| Eli Lilly And Company | HUMATROPE | somatropin | For Injection | 019640 | October 16, 1986 | ⤷ Start Trial | 2037-11-28 |
| Eli Lilly And Company | HUMATROPE | somatropin | For Injection | 019640 | February 04, 1999 | ⤷ Start Trial | 2037-11-28 |
| Emd Serono, Inc. | SAIZEN | somatropin | For Injection | 019764 | October 08, 1996 | ⤷ Start Trial | 2037-11-28 |
| Emd Serono, Inc. | SAIZEN | somatropin | For Injection | 019764 | August 29, 2000 | ⤷ Start Trial | 2037-11-28 |
| Emd Serono, Inc. | SAIZEN | somatropin | For Injection | 019764 | January 16, 2007 | ⤷ Start Trial | 2037-11-28 |
| Ferring Pharmaceuticals Inc. | ZOMACTON | somatropin | For Injection | 019774 | May 25, 1995 | ⤷ Start Trial | 2037-11-28 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
